It will likely take another five to 10 years before new pain medicines that could replace today’s opioids could reach the market, said Nora Volkow, director of the National Institute on Drug Abuse.
The NIDA director said the agency has been working with FDA, NIH and industry partners “to figure out ways that can accelerate the process of bringing analgesic products that are safer and effective.” But Volkow said society can’t dismiss a medicine because it carries risks of addiction. The task is to manage that risk in ways that keep patients safe.
She also emphasized the importance of FDA requiring long-term studies of pain medicine, even if those are conducted following marketing approval.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »